title: [Immunohepatologic and clinical monitoring of neuramide therapy in acute viral hepatitis B].
abstract: The authors carried out a double blind therapeutic trial with neuramide in 20 drug addicts affected by acute type B anti-delta negative viral hepatitis. The H/S ratio together with the most important clinical and hepatological parameters seem to improve following treatment.
authors.forename: S
authors.initials: S
authors.lastname: Corridori
authors.forename: G
authors.initials: G
authors.lastname: Trespi
authors.forename: E
authors.initials: E
authors.lastname: Baldini
authors.forename: D
authors.initials: D
authors.lastname: Campisi
authors.forename: I
authors.initials: I
authors.lastname: Renzetti
authors.forename: W
authors.initials: W
authors.lastname: Calderon
mesh_terms: D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000276:immunology; D023181:Antimicrobial Cationic Peptides; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006509:Hepatitis B / Q000188:drug therapy*; D006510:Hepatitis B Antibodies / Q000032:analysis; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006513:Hepatitis B e Antigens / Q000032:analysis; D006801:Humans; D007075:Immunoglobulin M / Q000032:analysis; D007694:Killer Cells, Natural / Q000276:immunology; D008297:Male; D010455:Peptides / Q000627:therapeutic use*; D010919:Placebos; D019966:Substance-Related Disorders; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D023181:Antimicrobial Cationic Peptides; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; D007075:Immunoglobulin M; D010455:Peptides; D010919:Placebos; C039202:neuramide
vernacular_title: Monitoraggio immunoepatologico e clinico di una terapia con neuramide nella virus epatite acuta tipo B.